D
Axsome Therapeutics, Inc. AXSM
$121.91 $0.260.21%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -20.05% -54.07% -67.28% -86.73% -27.84%
Total Depreciation and Amortization 16.45% 12.36% 8.69% 21.75% 55.25%
Total Amortization of Deferred Charges 2.56% -3.24% 2.09% 41.49% 73.57%
Total Other Non-Cash Items 1.03% 119.90% 103.79% 157.43% 175.50%
Change in Net Operating Assets 219.40% 262.22% 127.68% -270.68% -219.95%
Cash from Operations 11.49% 6.83% -50.22% -114.91% -24.52%
Capital Expenditure 53.61% 67.33% -17.07% -8.94% 17.09%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 53.61% 67.33% -17.07% 98.86% 98.92%
Total Debt Issued -- -100.00% -100.00% -70.00% 88.89%
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -73.65% -79.83% -85.72% 24.67% 8.46%
Repurchase of Common Stock -115.37% -115.31% -120.50% -97.40% -244.92%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 62.77% 70.53% 64.18% -73.26% -135.57%
Cash from Financing -82.53% -86.87% -90.21% -8.78% 16.32%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -138.22% -147.20% -133.39% -47.51% 62.06%
Weiss Ratings